Research Fellow Chief Technician Liverpool Regional Paraplegic Centre, Southport. NALIDIXIc acid is one of a series of 1, 8-naphthyridine derivatives. The chemistry, pharmacology and toxicology have been detailed elsewhere, Lishman and Swinney (1963) and Ward-McQuaid, Jichlinski and Macis (1963) . In a number of clinical trials published recently this chemotherapeutic agent was shown to be very effective against Gram-negative organisms in urinary tract infections, Lishman and Swinney (1963) , Jameson and Swinney (1963) , Slade (1963) , Barlow (1963) , WardMcQuaid and colleagues (1963) , Thompson and Rae (1964) , McCabe (1963 ), Carroll (1963 and Gibbon, Benstead and Misra (1965) .
On the basis of this information we investigated 22 acute and chronic cases of urinary tract infection with follow-up for 1-5 months.
Mehods and Material
These cases were selected at random for trial with nalidixic acid on the basis of clinical and bacteriological findings. Nine of the patients were below 60 years of age, and 13 were over 60. Fourteen patients were male and eight female. Eighteen patients were given 1 g. nalidixic acid by mouth every six hours until the infection was either cleared or obviously not responding to treatment. The other four patients were given 0.5 g. every six hours. The usual duration of treatment was 5-7 days, but in three cases it was continued for 15 days. Eight acute and six chronic cases took part in this trial.
Daily urine examinations were made from the start of therapy until completion. Midstream specimens were collected except in eight cases who had indwelling catheters where the collection was made in the manner described by Gibbon and colleagues (1965) .
Follow-up urine tests were made periodically on those patients who were bacteriologically cleared, this period varying (to date) from one to five months after therapy.
Culture, disc-sensitivity, bacterial and pus cell counts were performed on all specimens as detailed elsewhere (Gibbon and colleagues, 1965) . Organisms that developed resistance during therapy were subcultured daily in nutrient broth, up to 15 transferences being made. Disc sensitivity tests using commercially available 30 ,tg. nalidixic acid discs, were made on each day's subculture to determine whether any organism would regain sensitivity.
Results
The diagnosis of the underlying lesion is given in Table 1 .
Thirteen patients were cured, seven from the acute cases and six from the chronic ( Table 2 ). The rate of bacteriological clearance is shown in Table 3 . All strains were cleared by the fourth day after commencement of therapy.
The immediate results in the acute cases show a cure rate of 88 % and in the chronic cases one of 43 %. Out of the failures, that is one acute case and eight chronic cases, the acute and six of the chronic cases Table 4 .
Comparative disc sensitivities of 153 strains of Gram-negative bacilli isolated from urinary tract infections are shown in Table 5 . This includes the organisms isolated from the urine of the patients in this series.
The pus cell count of 11 patients showed a complete clearance (Table 6 ). Ten of these were cleared bacteriologically and the other developed a resistant E. coli. Three patients were cleared bacterio- logically but the pus cell count although falling, remained at a high level. Two of these became reinfected. The third, while maintaining clearance on culture after three months, still has a high pus cell count but it is falling. The count of the other eight patients was highly variable. Subculture of strain which acquired resistance: Five strains, three E. coli and 2 Proteus spp. developed resistance during therapy. One Proteus Side Effects.-Three patients had mild reactions to regained sensitivity after the sixth subculture, as judged by the disc technique, but the other four remained resistant. Side Effects:-Three patients had mild reactions to the drug. One had nausea with drowsiness and mild depression and another, diarrhoea with colicky abdominal pain. These symptoms cleared quickly on stopping the drug. The other patient complained of dizziness which settled after the dosage was reduced.
Discussion
Our results on the whole are comparable to those of other authors, Barlow (1963) , WardMcQuaid and others (1963), Carroll (1963) , Garrod, Shooter and Curwen (1964) , Kass (1955) , Rhoads, Billings and O'Conor (1952), Turck, Browder, Lindemeyer, Brown, Anderson and Petersdorf (1962) . The cure rate in acute infections, that is 7/8, is similar to that obtained by Barlow (1963) , Ward-McQuaid and others (1963) and Carroll (1963) .
The cure rate of the chronic cases (43 %) has not been as good as that of Barlow (1963) with 70%, or Mc-Quaid and others (1963) with 58%, possibly due to the fact that some of our patients were cases of prolonged infection with severely diseased bladders. Those who had urinary obstruc-tion due to carcinoma of the prostate, etc. would have, in any case, harboured infection whatever treatment was given.
Our follow-up results are similar to those of Barlow (1963) , but we have continued follow-up for a longer period. 6/7 acute and 2/6 chronic cases are still maintaining clearance.
Five resistant strains appeared in five patients, all chronic, and the development of resistance was rapid, irrespective of dosage.
Side-effects, which were mild, were slightly but not significantly higher than those reported by other authors.
Our results of the disc sensitivity tests broadly agree with the results of other authors, only slight variations having been noted (Barlow, 1963) , Thompson and Rae, 1964; Ward-McQuaid and others, 1963) . The results are similar to those of Gibbon and others (1965) .
Daily cultures showed that in those cases who were cleared bacteriologically the organisms disappeared from the urine within four days of commencement of therapy. This was also noted in the series studied by Gibbon and others (1965) and agrees with their suggestion and that of Barlow (1963) 
